1. Home
  2. BORR vs MPLT Comparison

BORR vs MPLT Comparison

Compare BORR & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

N/A

Current Price

$4.46

Market Cap

1.4B

Sector

Energy

ML Signal

N/A

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$12.54

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BORR
MPLT
Founded
2016
2018
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
BORR
MPLT
Price
$4.46
$12.54
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$6.25
$32.67
AVG Volume (30 Days)
5.7M
1.3M
Earning Date
05-20-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.39
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.80
N/A
Revenue Next Year
$21.67
N/A
P/E Ratio
$20.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$9.10
52 Week High
$6.66
$40.43

Technical Indicators

Market Signals
Indicator
BORR
MPLT
Relative Strength Index (RSI) 56.99 31.90
Support Level $3.74 $10.83
Resistance Level $4.51 $20.20
Average True Range (ATR) 0.21 0.93
MACD 0.05 0.66
Stochastic Oscillator 80.52 35.08

Price Performance

Historical Comparison
BORR
MPLT

About BORR Borr Drilling Limited

Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: